consent for semaglutide forms Prior Authorization Reimbursement Request Form Semaglutide Weight Loss Injection Consent

WeightWatchers app includes GLP-1-specific features like injection logging (tracking medication, dose, site, and side effects), protein and fibre tracking, on-demand strength training videos, and access to over 12,000 recipes

Stopping semaglutide abruptly often leads to rapid rebound, with reports of a 50% increase in appetite within the first week, and about 70% of patients experience weight regain after abrupt discontinuation

Retatrutide is a triple agonist (GIP/GLP-1/glucagon) currently in clinical trials that has shown weight loss exceeding 24% of body weight

This is particularly concerning for those relying on it to control their blood glucose levels or aid in weight loss